LANREOTIDE for Carcinoid syndrome: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 581 adverse event reports in the FDA FAERS database where LANREOTIDE was used for Carcinoid syndrome.
Most Reported Side Effects for LANREOTIDE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Diarrhoea | 1,646 | 18.3% | 66 | 418 |
| Off label use | 1,536 | 17.1% | 277 | 470 |
| Death | 1,177 | 13.1% | 1,177 | 215 |
| Fatigue | 1,022 | 11.4% | 44 | 307 |
| Nausea | 775 | 8.6% | 36 | 252 |
| Abdominal pain | 662 | 7.4% | 70 | 288 |
| Injection site pain | 618 | 6.9% | 21 | 105 |
| Malaise | 520 | 5.8% | 44 | 222 |
| Headache | 515 | 5.7% | 11 | 126 |
| Asthenia | 483 | 5.4% | 67 | 218 |
| Vomiting | 468 | 5.2% | 46 | 258 |
| Pain | 451 | 5.0% | 35 | 179 |
| Dizziness | 441 | 4.9% | 12 | 144 |
| Weight decreased | 430 | 4.8% | 43 | 208 |
| Injection site mass | 400 | 4.4% | 12 | 72 |
Other Indications for LANREOTIDE
Neuroendocrine tumour (2,629)
Acromegaly (1,956)
Product used for unknown indication (1,419)
Gastroenteropancreatic neuroendocrine tumour disease (586)
Carcinoid tumour (496)
Off label use (429)
Carcinoid tumour of the small bowel (298)
Pancreatic neuroendocrine tumour (232)
Gigantism (112)
Pancreatic carcinoma (85)
Other Drugs Used for Carcinoid syndrome
TELOTRISTAT ETHYL (2,954)
OCTREOTIDE (1,367)
EVEROLIMUS (128)
SANDOSTATIN LAR (31)
SUNITINIB MALATE (15)
CAPECITABINE (13)
TEMOZOLOMIDE (11)
SANDOSTATIN LAR DEPOT (9)
BEVACIZUMAB (8)
OCTREOTIDE\OCTREOTIDE (8)